Dexmedetomidine protects against sepsis-induced lung injury through autophagy and Smad2/3 signaling pathway.

Autor: Zhanli Liu¹, Jiqing Xu², Yanqiu Zhao³, Yanbin Wan³, Rui Guo³, Canling Long³, Jia Liu³, Xinhuang Yao³ yxhh25@126.com, Wenchao Yin⁴ yinwenchao2018@163.com

Publikováno v: Iranian Journal of Basic Medical Sciences. Apr2024, Vol. 27 Issue 4, p453-460. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Autor: Zia-Amirhosseini P; SmithKline Beecham Pharmaceuticals, Department of Drug Metabolism and Pharmacokinetics, King of Prussia, Pennsylvania, USA. parnian_zia-amirhosseini-1@sbphrd.com, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB

Publikováno v: Pharmaceutical research [Pharm Res] 2000 Apr; Vol. 17 (4), pp. 385-90.

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction.

Autor: Goode HF; Clinical Oxidant Research Group, St. James's University Hospital, UK., Cowley HC, Walker BE, Howdle PD, Webster NR

Publikováno v: Critical care medicine [Crit Care Med] 1995 Apr; Vol. 23 (4), pp. 646-51.

Clinical Radiology Orals.

Publikováno v: Journal of Medical Imaging & Radiation Oncology. Oct2022 Supplement S1, Vol. 66, p4-51. 48p.